Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →31
🟠 Elevated
🤖 ML Fraud Detection Score: 85%
Machine learning model identifies prescribing patterns consistent with confirmed fraud cases. This is a statistical indicator, not an accusation.
Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
14,794
Total Claims
$991K
Drug Cost
361
Beneficiaries
$2,746
Cost/Patient
Risk Score Breakdown 31/100
Score components are additive. Read full methodology
Peer Comparison vs. 110,156 Internal Medicine providers
+38%
Opioid rate vs peers
3.1% vs 2.2% avg
+95%
Cost per patient vs peers
$2,746 vs $1,411 avg
+17%
Brand preference vs peers
12.5% vs 10.6% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
Opioid Prescribing
3.1%
Opioid Rate
458
Opioid Claims
$13K
Opioid Cost
17.2%
Long-Acting Rate
Brand vs Generic
Brand: 1,827 claims · $662K
Generic: 12,833 claims · $319K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 375 | $157K |
| Pimavanserin Tartrate | 52 | $125K |
| Rivaroxaban | 81 | $35K |
| Mirabegron | 105 | $33K |
| Teriparatide | 11 | $29K |
| Insulin Detemir | 122 | $19K |
| Fluticasone Propion/Salmeterol | 47 | $18K |
| Insulin Glargine,hum.Rec.Anlog | 149 | $18K |
| Insulin Aspart | 100 | $15K |
| Dulaglutide | 15 | $15K |
| Eslicarbazepine Acetate | 12 | $14K |
| Atorvastatin Calcium | 666 | $14K |
| Carbidopa/Levodopa | 23 | $11K |
| Ipratropium/Albuterol Sulfate | 22 | $11K |
| Empagliflozin | 19 | $11K |
Prescribing Profile
Patient Profile
84
Avg Age
73%
Female
1.98
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About